MissionIR Articles
Category: Telomir Pharmaceuticals Inc. TELO
-
MissionIRNewsBreaks – Telomir Pharmaceuticals (NASDAQ: TELO) Closes TELI Acquisition, Secures Global Rights to Telomir-1
Telomir Pharmaceuticals (NASDAQ: TELO) announced the closing of its acquisition of TELI Pharmaceuticals, Inc., establishing the company as the sole global rights holder of Telomir-1 (Telomir-Zn) and eliminating prior geographic fragmentation of the asset. The…
-
MissionIRNewsBreaks – Telomir Pharmaceuticals Inc. (NASDAQ: TELO) Appoints Pharmaceutical Innovation Veteran as Chief Scientific Advisor
Telomir Pharmaceuticals (NASDAQ: TELO), a pre-clinical-stage company seeking to lead developments in longevity science through the treatment of age-related conditions, today announced the appointment of Dr. Itzchak Angel as Chief Scientific Advisor. Dr. Angel’s extensive…
Search Articles
Latest Articles
- MissionIRNewsBreaks – Lantern Pharma (NASDAQ: LTRN) Expands predictBBB Platform Into Large Quantitative Model for Drug Discovery
- MissionIRNewsBreaks – Greenland Energy Company (NASDAQ: GLND) Featured in EnergyWireNews Editorial on Global Energy Security
- MissionIRNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) to Report First Quarter Fiscal Year 2026 Financial Results on May 12, 2026
- MissionIRNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Secures $120M Term Sheet With Scilex for Quantum-Ready Edge Network Buildout
- MissionIRNewsBreaks – Massimo Group (NASDAQ: MAMO) Expands Fleet Sales Pipeline Following NAFA 2026 Engagement